Zynerba Pharmaceuticals Stock Forecast - Naive Prediction
| ZYNEDelisted Stock | USD 0.36 0.01 2.70% |
The Naive Prediction forecasted value of Zynerba Pharmaceuticals on the next trading day is expected to be 0.38 with a mean absolute deviation of 0.01 and the sum of the absolute errors of 0.65. Zynerba Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Zynerba Pharmaceuticals stock prices and determine the direction of Zynerba Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Zynerba Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Zynerba |
Zynerba Pharmaceuticals Naive Prediction Price Forecast For the 28th of November
Given 90 days horizon, the Naive Prediction forecasted value of Zynerba Pharmaceuticals on the next trading day is expected to be 0.38 with a mean absolute deviation of 0.01, mean absolute percentage error of 0.0002, and the sum of the absolute errors of 0.65.Please note that although there have been many attempts to predict Zynerba Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Zynerba Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Zynerba Pharmaceuticals Stock Forecast Pattern
| Backtest Zynerba Pharmaceuticals | Zynerba Pharmaceuticals Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Zynerba Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Zynerba Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 109.4434 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0107 |
| MAPE | Mean absolute percentage error | 0.0312 |
| SAE | Sum of the absolute errors | 0.6521 |
Predictive Modules for Zynerba Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Zynerba Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.View Zynerba Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Zynerba Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Zynerba Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Zynerba Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Zynerba Pharmaceuticals stock market strength indicators, traders can identify Zynerba Pharmaceuticals entry and exit signals to maximize returns.
Zynerba Pharmaceuticals Risk Indicators
The analysis of Zynerba Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Zynerba Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting zynerba stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.36 | |||
| Standard Deviation | 4.2 | |||
| Variance | 17.63 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Zynerba Stock
If you are still planning to invest in Zynerba Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zynerba Pharmaceuticals' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |